It’s been going on far too long – and it’s not over yet.
I’m talking about the High Court action against GlaxoSmithKline that is being taken by a group of UK patients who are determined to finally have their day in court confronting GlaxoSmithKline.
It’s a long story and goes back 10 years or more. It’s also a complicated story and one which I am sure will be told in full one day.
You can find the full details of the Seroxat Group Action here at the Fortitude Law website:
Following the halt of the Seroxat Group Action in 2010 when public funding was withdrawn, Claimants determined to continue with their claims for compensation have turned to Fortitude Law. We are now set to return to Court and confront GlaxoSmithKline (UK) Ltd. with evidence of the harm they suffered as a consequence of having become dependent upon the antidepressant, Seroxat. Fortitude Law is working with Counsel Jacqueline Perry QC and Niazi Fetto, 2 Temple Garden Chambers, London to represent 105 Claimants in their High Court claims.
Patients were reassured by their GPs that unlike other antidepressants, they would be able to stop taking Seroxat whenever they wanted. Instead, over 6,000 individuals advised their GPs that each time they reduced their dose they suffered bizarre and debilitating symptoms not previously experienced. These symptoms often included impulsive suicidal thoughts, thoughts of self harm and uncharacteristic aggressive behavior. Their withdrawal symptoms were so severe that the only way they could be avoided was to return to their previous daily dose.
To see the genesis of this litigation, which first commenced with the BBC’s Panorama Programme ‘Secrets of Seroxat’ first shown in 2002, visit news.bbc.co.uk/2/hi/programmes/panorama/2310197.stm
